Nuage Therapeutics welcomes Olivier Corminboeuf and Blandine Guimet to Leadership Team

Olivier joined Nuage Therapeutics as Head of Drug Discovery. Prior to this, he served as Head of Medicinal Chemistry at Idorsia. Olivier brings extensive expertise in medicinal chemistry from his roles at both Idorsia and Actelion, with a particular focus on oncology and immunology. Over the course of his career, Olivier has contributed to the discovery of multiple drug candidates that have progressed into clinical development.

Commenting on his appointment, Dr. Corminboeuf, new Head of Drug Discovery at Nuage Tx, said: “I’m thrilled to join Nuage Therapeutics at such an exciting moment. Nuage is pioneering a disruptive platform that redefines what’s possible in drug discovery—by turning intrinsically disordered proteins (IDPs), long considered ‘undruggable,’ into druggable therapeutic targets. This breakthrough opens entirely new avenues for precision medicine, and I look forward to helping advance Nuage’s pipeline to bring impactful therapies to patients.”

Blandine Guimet stepped into the role of Head of People. Blandine has extensive expertise in Human Resources gained through operational and strategic roles within corporate and start-ups environments. In 2021, Blandine founded Start HR Consulting, a company that provides support to biotech companies with their HR needs through their early and growth phases. Blandine holds a MA in Human Resources Management and is certified in co-active coaching.

As she joins the leadership team, Blandine shared: “It’s a real pleasure to be part of Nuage Therapeutics’ journey at such a key moment. I’m looking forward to helping build the foundations that will support our teams as we grow — through strong, scalable people practices and a culture where everyone feels empowered, supported, and inspired to do their best work.”

Their leadership will be instrumental as we continue to grow, evolve and push boundaries – delivering a new wave of transformative therapies by unlocking the druggability of intrinsically disordered proteins (IDPs).

Welcome on board Olivier and Blandine!